These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 7986401)

  • 1. The immunosuppressive peptide of HIV-1: functional domains and immune response in AIDS patients.
    Denner J; Norley S; Kurth R
    AIDS; 1994 Aug; 8(8):1063-72. PubMed ID: 7986401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The immunosuppressive peptide of HIV-1 inhibits T and B lymphocyte stimulation.
    Denner J; Persin C; Vogel T; Haustein D; Norley S; Kurth R
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Aug; 12(5):442-50. PubMed ID: 8757420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A combinatorial peptide library around variation of the human immunodeficiency virus (HIV-1) V3 domain leads to distinct T helper cell responses.
    Estaquier J; Boutillon C; Georges B; Ameisen JC; Tartar A; Auriault C
    J Pept Sci; 1996; 2(3):165-75. PubMed ID: 9231325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The CBD1 peptide corresponding to the caveolin-1 binding domain of HIV-1 glycoprotein gp41 elicits neutralizing antibodies in cynomolgus macaques when administered with the tetanus T helper epitope.
    Benferhat R; Martinon F; Krust B; Le Grand R; Hovanessian AG
    Mol Immunol; 2009 Feb; 46(4):705-12. PubMed ID: 19010547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of natural killer cell activities from normal donors and AIDS patients by envelope peptides from human immunodeficiency virus type I.
    Nair MP; Schwartz SA
    Cell Mol Biol (Noisy-le-grand); 1997 Nov; 43(7):969-79. PubMed ID: 9449529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of immune suppression by a synthetic HIV gp41 peptide.
    Wang H; Nishanian P; Fahey JL
    Cell Immunol; 1995 Apr; 161(2):236-43. PubMed ID: 7697734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-1 vaccine development: constrained peptide immunogens show improved binding to the anti-HIV-1 gp41 MAb.
    McGaughey GB; Citron M; Danzeisen RC; Freidinger RM; Garsky VM; Hurni WM; Joyce JG; Liang X; Miller M; Shiver J; Bogusky MJ
    Biochemistry; 2003 Mar; 42(11):3214-23. PubMed ID: 12641452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenic and antigenic dominance of a nonneutralizing epitope over a highly conserved neutralizing epitope in the gp41 envelope glycoprotein of human immunodeficiency virus type 1: its deletion leads to a strong neutralizing response.
    Cleveland SM; Buratti E; Jones TD; North P; Baralle F; McLain L; McInerney T; Durrani Z; Dimmock NJ
    Virology; 2000 Jan; 266(1):66-78. PubMed ID: 10612661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AIDS: an immune response against the immune system. Role of a precise tridimensional molecular mimicry.
    Serres PF
    J Autoimmun; 2001 May; 16(3):287-91. PubMed ID: 11334494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of a novel human immunodeficiency virus type 1 neutralizable epitope within the immunodominant region of gp41.
    Viveros M; Dickey C; Cotropia JP; Gevorkian G; Larralde C; Broliden K; Levi M; Burgess A; Cao C; Weiner DB; Agadjanyan MG; Ugen KE
    Virology; 2000 Apr; 270(1):135-45. PubMed ID: 10772986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T cell recognition of HIV synthetic peptides in a natural infection.
    Schrier RD; Gnann JW; Landes R; Lockshin C; Richman D; McCutchan A; Kennedy C; Oldstone MB; Nelson JA
    J Immunol; 1989 Feb; 142(4):1166-76. PubMed ID: 2783706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Collection of phage-peptide probes for HIV-1 immunodominant loop-epitope.
    Palacios-Rodríguez Y; Gazarian T; Rowley M; Majluf-Cruz A; Gazarian K
    J Microbiol Methods; 2007 Feb; 68(2):225-35. PubMed ID: 17046088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-1 neutralizing antibodies elicited by the candidate CBD1 epitope vaccine react with the conserved caveolin-1 binding motif of viral glycoprotein gp41.
    Rey-Cuillé MA; Svab J; Benferhat R; Krust B; Briand JP; Muller S; Hovanessian AG
    J Pharm Pharmacol; 2006 Jun; 58(6):759-67. PubMed ID: 16734977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of HIV/AIDS vaccine using chimeric gag-env virus-like particles.
    Kang CY; Luo L; Wainberg MA; Li Y
    Biol Chem; 1999 Mar; 380(3):353-64. PubMed ID: 10223338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the interacting domain of the HIV-1 fusion peptide with the transmembrane domain of the T-cell receptor.
    Cohen T; Pevsner-Fischer M; Cohen N; Cohen IR; Shai Y
    Biochemistry; 2008 Apr; 47(16):4826-33. PubMed ID: 18376816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The caveolin-1 binding domain of HIV-1 glycoprotein gp41 (CBD1) contains several overlapping neutralizing epitopes.
    Benferhat R; Krust B; Rey-Cuillé MA; Hovanessian AG
    Vaccine; 2009 Jun; 27(27):3620-30. PubMed ID: 19464543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical studies on immunogenicity of the HIV-1 p17-based synthetic peptide AT20-KLH.
    Fiorentini S; Marini E; Bozzo L; Trainini L; Saadoune L; Avolio M; Pontillo A; Bonfanti C; Sarmientos P; Caruso A
    Biopolymers; 2004; 76(4):334-43. PubMed ID: 15386266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Common epitope in human immunodeficiency virus (HIV) I-GP41 and HLA class II elicits immunosuppressive autoantibodies capable of contributing to immune dysfunction in HIV I-infected individuals.
    Golding H; Shearer GM; Hillman K; Lucas P; Manischewitz J; Zajac RA; Clerici M; Gress RE; Boswell RN; Golding B
    J Clin Invest; 1989 Apr; 83(4):1430-5. PubMed ID: 2467924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of protein kinase C and anti-CD3-induced Ca2+ influx in Jurkat T cells by a synthetic peptide with sequence identity to HIV-1 gp41.
    Ruegg CL; Strand M
    J Immunol; 1990 May; 144(10):3928-35. PubMed ID: 2139676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the HIV-1 gp41 specific immune response using a multiplexed antibody detection assay.
    Opalka D; Pessi A; Bianchi E; Ciliberto G; Schleif W; McElhaugh M; Danzeisen R; Geleziunas R; Miller M; Eckert DM; Bramhill D; Joyce J; Cook J; Magilton W; Shiver J; Emini E; Esser MT
    J Immunol Methods; 2004 Apr; 287(1-2):49-65. PubMed ID: 15099755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.